Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

October 2019

Feature

Plastibytes
10/21/2019

Katherine H. Carruthers, MD, MS,a Ergun Kocak, MD, MS,b Pankaj Tiwari, MD,b and Shunsuke Yoshida, MDb

Katherine H. Carruthers, MD, MS,a Erg...
A method for augmenting venous outflow in the SGAP flap in the setting of autologous breast reconstruction is reported.
A method for augmenting venous outflow in the SGAP flap in the setting of autologous breast reconstruction is reported.
A method for augmenting venous...
10/21/2019
ePlasty
Research Reports
10/18/2019
Teresita Muñoz-Antonia, PhD
Vani N Simmons, PhD
Steven K Sutton, PhD
Matthew B Schabath, PhD
Iffat Alam
Alberto Chiappori, MD
Gwendolyn P Quinn, PhD
Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...
Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...
...
10/18/2019
Journal of Clinical Pathways
Research Reports
10/18/2019
Caroline Hudson, MD
David C Wilde, MD
Andrew T Huang, MD
David Hernandez, MD
Anita L Sabichi, MD
George Chen, MD
Peter Gerngross, DDS
Banner Logan, DDS, MD
Ricky Morlen, DMD
Scott Charnitsky, PA
Robert Parke, MD
Vlad C Sandulache, MD, PhD
Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...
Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...
Abstract: The Veterans...
10/18/2019
Journal of Clinical Pathways

Column

Editor's Page
10/18/2019
Winston Wong, PharmD, Editor-in-Chief
Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...
Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...
Even...
10/18/2019
Journal of Clinical Pathways
Editorial
10/18/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...
In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...
In...
10/18/2019
Journal of Clinical Pathways
Business of Pathways
10/18/2019
Sean McElligott, MS
Ira Klein, MD, MBA, FACP—Column Editor
*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...
*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...
...
10/18/2019
Journal of Clinical Pathways

News

Conference Coverage
10/18/2019
JCP Editors
Now in its fourth year, the Oncology Clinical Pathways Congress (OCPC) serves as a forum for oncology care professionals interested in utilizing clinical pathways as a tool to facilitate more value-based care...
Now in its fourth year, the Oncology Clinical Pathways Congress (OCPC) serves as a forum for oncology care professionals interested in utilizing clinical pathways as a tool to facilitate more value-based care...
Now...
10/18/2019
Journal of Clinical Pathways
Conference Coverage
10/18/2019
JCP Editors
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 27.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 10.0px Helvetica} p.p3...
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 27.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 10.0px Helvetica} p.p3...
p.p1...
10/18/2019
Journal of Clinical Pathways

Insights

Interview
10/18/2019
JCP Editors
Journal of Clinical Pathways (JCP) spoke with faculty at the University Hospitals Seidman Cancer Center, Cleveland, OH, regarding their unique positioning for cancer treatment in the greater Cleveland area and within...
Journal of Clinical Pathways (JCP) spoke with faculty at the University Hospitals Seidman Cancer Center, Cleveland, OH, regarding their unique positioning for cancer treatment in the greater Cleveland area and within...
...
10/18/2019
Journal of Clinical Pathways

Tools and Resources

Tools for Transformation
10/18/2019
Gordon Kuntz—Column Editor
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon...
10/18/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement